Nando, a leading Lithuanian-owned biotechnology company, known for its groundbreaking work in developing microbiological products for agriculture, has announced a significant bolstering of its management team and an ambitious expansion of its biotechnological production line.
This move is set to position Nando, not just as a leader in Lithuania, but as a major player on the international stage.
In a strategic enhancement of its management team, Nando welcomes four seasoned professionals, each bringing a wealth of experience from reputable organizations. Gytis Kubilius, Mindaugas Navickas, Arūnas Jusas and Giedrė Mockienė who are now all integral parts of Nando’s leadership, aiming to spearhead ambitious development projects.
To cater to the surging demand for microbiological alternatives to mineral fertilisers and plant protection products, Nando has invested about €3 million in a unique biotechnology line. This investment boosts production volume, enhances productivity and ensures competitive pricing to meet the escalating market demand. With a technology that is currently patent-pending, Nando exports to over 20 countries including Great Britain, Ukraine, Estonia, Kazakhstan, Latvia, Poland, Romania and beyond.